Description
Empagliflozin 25 mg IR is an oral antidiabetic medication used for managing type 2 diabetes mellitus. It belongs to the SGLT2 inhibitor class, which works by preventing glucose reabsorption in the kidneys, thereby increasing urinary glucose excretion and lowering blood sugar levels. This immediate-release (IR) formulation ensures quick absorption and effective glycemic control. Empagliflozin also supports cardiovascular health by reducing the risk of heart failure in patients with type 2 diabetes.
